Neurolief announced today that the FDA granted approval for its Proliv Rx at-home neuromodulation therapy for treating ...

As we enter 2026, there are two distinct technologies used by clinicians to interact with the brain: Brain-Computer Interfaces and Neuromodulation.

TIESA will use Open-LIFU in AI-guided, noninvasive research on neuromodulation for mental health conditions. SAN ...

ImagineHealth and Vivatronix partner to bring SpineX’s neuromodulation technology to global markets, enhancing recovery for neurological condition patients. Patients have been waiting for a solution ...

ReShape Lifesciences has received a Notice of Allowance from the U.S. Patent and Trademark Office for its patent application on a new Diabetes Neuromodulation system utilizing its vagal nerve block ...

The R&D on neuromodulation technology for the treatment and management of metabolic syndrome conducted by a team led by Dr. Ki-young Shin of Human Care Electro-Medical Device Research Center, ...

ReShape Lifesciences® announced the granting of an international patent for its Diabetes Neuromodulation technology from the Australian Patent Office, providing protection until April 12, 2039. This ...

IRVINE, Calif.--(BUSINESS WIRE)--Axonics Modulation Technologies, Inc., developer of the first rechargeable Sacral Neuromodulation (r-SNM™) system for the treatment of urinary and fecal dysfunction, ...

Chicago, Nov. 20, 2025 (GLOBE NEWSWIRE) -- The global internal neuromodulation devices market was valued at US$ 11.81 billion in 2024 and is expected to reach 44.57 billion by 2033, growing at a CAGR ...

PRETORIA, South Africa, May 14, 2018 /PRNewswire/ -- Xavant Technology (Pty) Ltd today announced its attendance at the upcoming 11 th Diabetologists Conference, which will be held in New York from May ...